AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 35669353
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment groups (Iv12, Iv24, Control)
Trial: 34538402
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Arm C)
Trial: 32720552
Drug: Er:YAG laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Er:YAG laser treatment
Trial: 35670036
Drug: pembrolizumab plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pembrolizumab plus low-dose SNK01 (2 × 10^9 cells/dose)
Trial: 33242419
Drug: Amantadine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amantadine (up to 100 mg twice daily)
Trial: 33242419
Drug: Modafinil (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modafinil (up to 100 mg twice daily)
Trial: 33242419
Drug: Methylphenidate (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methylphenidate (up to 10 mg twice daily)
Trial: 33588378
Drug: Exercise plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise plus presleep protein ingestion (40 g intrinsically-labeled casein protein after resistance-type exercise)
Trial: 33588378
Drug: Presleep protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Presleep protein ingestion (40 g intrinsically L-[1-13C]-phenylalanine and L-[1-13C]-leucine-labeled casein protein)
Trial: 34686472
Drug: R-miniCHOP chemoimmunotherapy
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-miniCHOP chemoimmunotherapy with oral azacitidine (CC-486)
Trial: 34686472
Drug: R-miniCHOP chemoimmunotherapy
RxNorm normalized name: pantolactone, (R)-
FDA approved: no
EMA approved: no
PMDA approved: no
Description: R-miniCHOP chemoimmunotherapy without oral azacitidine (CC-486)
Trial: 33358232
Drug: 400 mg
RxNorm normalized name: mesna 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 mg ibuprofen/1,000 mg acetaminophen
Trial: 33358232
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg codeine/300 mg acetaminophen
Trial: 33358232
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg hydrocodone/300 mg acetaminophen
Trial: 33358232
Drug: Opioids (codeine,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Opioids (codeine, hydrocodone, oxycodone)
Trial: 36027955
Drug: Prophylactic intravenous
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic intravenous amoxicillin and clavulanic acid
Trial: 35794079
Drug: HN0037 (10,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HN0037 (10, 30, 60, 120, 200, 300, and 400 mg single doses; 30 and 100 mg once daily for 14 days)
Trial: 33337539
Drug: Low-molecular-weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular-weight heparin (LMWH)
Trial: 616406917
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline administered in the same manner)
Trial: 35566210
Drug: BCP-SEDDS (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BCP-SEDDS (100 mg)
Trial: 33387724
Drug: Resveratrol (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resveratrol (400 mg) for 12–14 weeks
Trial: 33492303
Drug: Melatonin 5
RxNorm normalized name: melatonin 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melatonin 5 mg/d for 2 weeks
Trial: 34813408
Drug: Low-dose vaginal
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose vaginal 17β-estradiol tablets
Trial: 34264825
Drug: Automated algorithms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automated algorithms for predicting lung nodule malignancy from sequential LDCT scans
Trial: 33439486
Drug: Fostamatinib as
RxNorm normalized name: fostamatinib
DrugBank: Fostamatinib (DB12010)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Fostamatinib as second-line therapy
Trial: 33439486
Drug: Fostamatinib as
RxNorm normalized name: fostamatinib
DrugBank: Fostamatinib (DB12010)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Fostamatinib as third-or-later-line therapy
Trial: 35940841
Drug: Prescription digital
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prescription digital therapeutic (PDT) for mobile-delivered CBT-I (Somryst)
Trial: 34658285
Drug: Self-administered acupressure
RxNorm normalized name: corticotropin
DrugBank: Corticotropin (DB01285)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Self-administered acupressure and exercise
Trial: 34658285
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of acupressure and exercise
Trial: 33724592
Drug: Standardized extract
RxNorm normalized name: Spring Valley Olive Leaf Standardized Extract 150mg Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standardized extract of Opuntia ficus-indica (400 mg/day) for 8 weeks
Trial: 35986403
Drug: Tuina treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tuina treatment
Trial: 34351939
Drug: Prehypertension treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prehypertension treatment
Trial: 85049646
Drug: Ketoconazole 200
RxNorm normalized name: ketoconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 200 mg daily for 25 days
Trial: 34010843
Drug: Mirabegron (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mirabegron (50 mg once daily)
Trial: 35370486
Drug: Propranolol (nonselective
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (nonselective β-antagonist) administered for 1 week prior to and 4 weeks following HCT
Trial: 35370486
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no propranolol treatment)
Trial: 32558407
Drug: Escitalopram monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Escitalopram monotherapy
Trial: 33388444
Drug: Etonogestrel subdermal
RxNorm normalized name: etonogestrel
DrugBank: Etonogestrel (DB00294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Etonogestrel subdermal contraceptive implant (SCI)
Trial: 35348764
Drug: Polypharmacy (≥5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polypharmacy (≥5 medications)
Trial: 35348764
Drug: Excessive polypharmacy
RxNorm normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Excessive polypharmacy (≥10 medications)
Trial: 35348764
Drug: Potentially inappropriate
RxNorm normalized name: Potentilla discolor whole extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potentially inappropriate medications (PIM)
Trial: 35348764
Drug: Nonprescription medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonprescription medications
Trial: 35348764
Drug: Potential major
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potential major drug-drug interactions (DDI)
Trial: 32439189
Drug: Topical nitroglycerin
RxNorm normalized name: nitroglycerin Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nitroglycerin patch (5 mg) applied 1 hour before anesthesia
Trial: 32439189
Drug: Topical nitroglycerin
RxNorm normalized name: nitroglycerin Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nitroglycerin patch (5 mg)
Trial: 32356581
Drug: Triamcinolone acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolone acetonide (TCA) 4 mg
Trial: 36273203
Drug: HA-VTE risk
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HA-VTE risk probability calculated from a validated VTE risk-prediction model with daily updates and additional review by hematologists for patients with elevated risk (predicted probability of HA-VTE ≥ 0.025)
Trial: 32589630
Drug: Vienna Prediction
RxNorm normalized name: reductic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vienna Prediction Model (VPM) guided anticoagulant treatment
Trial: 33336888
Drug: Low-dose glucagon
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose glucagon (150 μg subcutaneous)
Trial: 35147085
Drug: Target-controlled plasma
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Target-controlled plasma infusion of lidocaine (3 mg/L) during induction and maintenance of anesthesia
Trial: 35866633
Drug: Marburg virus
RxNorm normalized name: Marburg virus Ag
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Marburg virus vaccine candidates
Trial: 33772416
Drug: Combined treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatments
Trial: 35426861
Drug: Amoxicillin-clavulanic acid
RxNorm normalized name: amoxicillin / clavulanate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amoxicillin-clavulanic acid
Trial: 35583217
Drug: Turner syndrome
RxNorm normalized name: Syndros
DrugBank: Dronabinol (DB00470)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Turner syndrome patients (TS) with orthodontic treatment
Trial: 34813098
Drug: Deep breathing
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deep breathing treatment video
Trial: 33210302
Drug: Low-dose tocilizumab
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose tocilizumab (40 to 200 mg, with allowance for one repeat dose at 24 to 48 hours)
Trial: 35279081
Drug: Guideline-based therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guideline-based therapy with amikacin liposome inhalation suspension
Trial: 33439274
Drug: Structured reporting
RxNorm normalized name: LIPID,STRUCTURED (FROM SUNFLOWER OIL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Structured reporting with digital solutions
Trial: 33439274
Drug: Standard reporting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard reporting without structured solutions
Trial: 34425554
Drug: SC79 injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC79 injection at 0.02 mg/kg bodyweight
Trial: 34425554
Drug: SC79 injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC79 injection at 0.04 mg/kg bodyweight
Trial: 33413212
Drug: Professional oral
RxNorm normalized name: Dentek Professional Oral Care Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Professional oral care (POC)
Trial: 33678517
Drug: Horizons +
RxNorm normalized name: Horizant
DrugBank: Gabapentin enacarbil (DB08872)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Horizons + Group Motivational Enhancement Therapy
Trial: 39379540
Drug: Intravenous antibiotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous antibiotics
Trial: 33296688
Drug: Higher-dose NOACs
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher-dose NOACs
Trial: 33296688
Drug: Lower-dose NOACs
RxNorm normalized name: flowers
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lower-dose NOACs
Trial: 34737220
Drug: Oral corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral corticosteroids (OCS) treatment
Trial: 34939318
Drug: Advised to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Advised to hand express for 10 minutes twice daily until birth (n=319)
Trial: 37944925
Drug: Uterosacral ligament
RxNorm normalized name: human ligament preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uterosacral ligament suspension (USLS)
Trial: 36030971
Drug: REVASC: 5.25%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: REVASC: 5.25% NaOCl, saline, and 1 g/mL TAP
Trial: 33242163
Drug: Loco-regional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Loco-regional treatment (LRT)
Trial: 36277940
Drug: Personalized home-based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Personalized home-based support including monthly visits focused on nutritional counseling and pregnancy monitoring.
Trial: 33154182
Drug: Listen-In therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Listen-In therapy (self-led therapy app)
Trial: 33269836
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment (once daily for 10 courses, 6 consecutive times each course) at points Quchi (LI11), Zusanli (ST36), Taichong (LR3), Hegu (LI4), Shenshu (BL23), Geshu (BL17), and Dazhui (GV14)
Trial: 33045193
Drug: Oral-fluid HIV
RxNorm normalized name: Fluad 2024-2025
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral-fluid HIV self-tests distributed during home visits; one present household member trained on self-test use.
Trial: 36244879
Drug: High-dose influenza
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose influenza vaccine (HD)
Trial: 32186653
Drug: 81 mg
RxNorm normalized name: aspirin 81 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 81 mg of aspirin daily
Trial: 32186653
Drug: 325 mg
RxNorm normalized name: lysine 325 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 325 mg of aspirin daily
Trial: 35588553
Drug: Placebo intervention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo intervention (sham analgesic cream) applied before and after heat stimulations
Trial: 35093029
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g oral dose of intra-partum azithromycin
Trial: 33539944
Drug: Cobimetinib (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cobimetinib (60 mg, D3-D23 of each 28-day cycle) plus paclitaxel (80 mg/m2, D1, 8, and 15)
Trial: 33539944
Drug: Cobimetinib plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cobimetinib plus atezolizumab (840 mg, D1 and D15) and nab-paclitaxel (100 mg/m2, D1, D8, and D15)
Trial: 35488544
Drug: Routine diagnosis
RxNorm normalized name: Peace Out Acne Hero Routine KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine diagnosis and treatment without vaccine (Control)
Trial: 35488544
Drug: HEV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HEV vaccine (3 doses)
Trial: 34274786
Drug: Antidepressants (ATDs)
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (ATDs) use for more than 180 days
Trial: 34274786
Drug: Antidepressants (ATDs)
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (ATDs) use of 180 > cDDD ? 28
Trial: 34274786
Drug: Antidepressants (ATDs)
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (ATDs) use of cDDD ? 180
Trial: 38499358
Drug: Oral acetaminophen
RxNorm normalized name: acetaminophen Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral acetaminophen
Trial: 33278331
Drug: Wearable Injector
RxNorm normalized name: WEARABLE INJECTOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wearable Injector (WI) delivering 5 mL subcutaneous placebo injections
Trial: 36036856
Drug: PL‐ASA (phospholipid‐aspirin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PL‐ASA (phospholipid‐aspirin liquid filled capsules)
Trial: 36036856
Drug: EC‐ASA (low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EC‐ASA (low dose enteric-coated aspirin)
Trial: 32023293
Drug: Mass drug
RxNorm normalized name: Xenon, isotope of mass 129
DrugBank: Xenon Xe-129 (DB17386)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mass drug administration (MDA) with dihydroartemisinin-piperaquine and single low-dose primaquine
Trial: 32891278
Drug: Peppermint essential
RxNorm normalized name: Nature's Truth Peppermint Essential Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Peppermint essential oil inhalation
Trial: 37245250
Drug: Carvedilol therapy
RxNorm normalized name: Carvedilol
DrugBank: Carvedilol (DB01136)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Carvedilol therapy
Trial: 34315413
Drug: Vaginal misoprostol
RxNorm normalized name: Misoprostol
DrugBank: Misoprostol (DB00929)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vaginal misoprostol (25 µg)
Trial: 35871120
Drug: HNLP (High
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HNLP (High Nitrate Low Phenolic) - 50g of lettuce containing 530mg nitrate and 11mg phenolic compounds
Trial: 35871120
Drug: LNHP (Low
FDA approved: no
EMA approved: no
PMDA approved: no
Description: LNHP (Low Nitrate High Phenolic) - 50g of lettuce containing 3mg nitrate and 77mg phenolic compounds
Trial: 33394979
Drug: Single Trigger
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single Trigger Point Injection (TPI)
Trial: 33499848
Drug: Intravenous TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous TXA (15 mg/kg in 100 mL of saline solution) administered 10 min before tourniquet release
Trial: 33499848
Drug: Intra-articular TXA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular TXA (15 mg/kg in 100 mL of saline solution) injected via drainage tube
Trial: 33499848
Drug: Placebo (equivalent
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (equivalent volume of normal saline administered into the knee joint cavity and intravenously)
Trial: 32646498
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (control)
Trial: 35986947
Drug: Methionine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methionine plus Disaccharide injection (25 g/L maltose + 25 g/L sucrose + 5 g/L Met + 7.5 g/L NaCl)
Trial: 35986947
Drug: Non-injection (control
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-injection (control group)
Trial: 34233152
Drug: Finite Difference
RxNorm normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finite Difference Method (FDM) for modeling tablet disintegration
Trial: 34389930
Drug: Insulin pumps
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin pumps
Trial: 38750866
Drug: Vonoprazan 10
RxNorm normalized name: vonoprazan 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vonoprazan 10 mg
Trial: 35798020
Drug: 50 g
RxNorm normalized name: glucose 50 g/296 mL oral liquid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g prunes
Trial: 32604121
Drug: Lu-DOTATATE (median
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lu-DOTATATE (median cumulative dose of 27 GBq, range 13.3-41.3 GBq, over 2-7 cycles) and 1250 mg/m capecitabine from days 0 to 14 of each PRRT cycle
Trial: 35719637
Drug: Two-agent chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Two-agent chemotherapy regimen (T+I)
Trial: 37192642
Drug: MDMA (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MDMA (100 mg)
Trial: 33558678
Drug: Topiramate (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate (200 mg/day)
Trial: 34959951
Drug: Potassium gluconate
RxNorm normalized name: Potassium Gluconate
DrugBank: Potassium gluconate (DB13620)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Potassium gluconate supplementation (1000 mg/day added to a basal diet of 2300 mg/day)
Trial: 34959951
Drug: Control (basal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (basal diet of 2300 mg/day potassium)
Trial: 35030036
Drug: Ibrutinib 560
RxNorm normalized name: ibrutinib 560 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibrutinib 560 mg once daily and rituximab 375 mg/m2 (total of eight doses)
Trial: 35656793
Drug: Treatment with
RxNorm normalized name: Campho-Phenique Cold Sore Treatment with Drying Action
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment with dupilumab
Trial: 35388606
Drug: Oral isotretinoin
RxNorm normalized name: Isotretinoin
DrugBank: Isotretinoin (DB00982)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral isotretinoin (0.5 mg/kg once daily for 16 weeks) + SM peeling (20% salicylic and 10% mandelic acid every four weeks for 16 weeks)
Trial: 32623812
Drug: Vitamin D3
RxNorm normalized name: Vitamin D3
DrugBank: Cholecalciferol (DB00169)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D3 supplementation (monthly for 2 years)
Trial: 33313936
Drug: Daylight photodynamic
RxNorm normalized name: calcium carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daylight photodynamic therapy (5 full-face sessions over 2 years)
Trial: 33313936
Drug: Daylight photodynamic
RxNorm normalized name: calcium carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daylight photodynamic therapy
Trial: 36424554
Drug: Left nostril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Left nostril (Group L, n=25)
Trial: 36424554
Drug: Left nostril
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Left nostril (Group L)
Trial: 33370024
Drug: Chemotherapy only
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy only
Trial: 33451057
Drug: 1.6 g
RxNorm normalized name: GLYCERIN 1241.6 g in 1 L TOPICAL LIQUID
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.6 g of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) per day (0.3 g EPA and 1.3 g DHA) in a microencapsulated powder
Trial: 32694001
Drug: Home-based physical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home-based physical exercise (60 minutes twice a week for 24 months)
Trial: 34849918
Drug: Both dosing
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both dosing regimens of etrolizumab